In a latest research revealed in the journal Rising Infectious Disorders, scientists investigated no matter if pet puppies and cats in the homes of critical acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-infected humans had been at risk of infection.
Research: Possibility Aspects for SARS-CoV-2 An infection and Health issues in Cats and Pet dogs. Graphic Credit rating: Sharomka / Shutterstock
Studies have shown that various species are susceptible to SARS-CoV-2 an infection, especially pet cats and canines residing close to individuals. They are the most exposed even so, beneath experimental circumstances, they are infected only transiently, demonstrating gentle signs.
In the Netherlands, captive minks contracted a viral an infection from people, which they retransmitted to humans and cats, and canines. In scarce situations, animals have died write-up contracting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection having said that, defining the contribution of SARS-CoV-2 to demise is demanding.
Though most viral bacterial infections in pets originate from human owners, risk variables for this sort of zoonotic transmission and the character and frequency of their medical illness are not well outlined.
About the analyze
In the present study, scientists investigated SARS-CoV-2 seropositivity in domestic pets and animals in shelters and neuter clinics in Ontario, Canada. Additionally, they applied univariable assessment to examine residence risk things relevant to SARS-CoV-2 seropositivity.
Seropositivity for SARS-CoV-2 in cats introduced for care to a low-price spay/neuter clinic through January – June 2021, Ontario, Canada. A) Exam results for 221 cats revealed by month. B) Positivity charge for each thirty day period. The points indicate the proportion of good examination success between all take a look at effects above time. Blue line signifies the smoothed price of seropositivity. The association in between thirty day period and the transform in seropositivity was substantial (p<0.0001).
The study veterinarians invited pet owners diagnosed with COVID-19 (in the previous three weeks) to bring in their pet dogs, cats, and ferrets for swab sample collection between April 2020 and August 2021. They collected swab samples from animals’ distal nares, oropharynx, and rectum. The median age of dogs and cats was five and six years, respectively.
The team first performed a quantitative reverse transcription-polymerase chain reaction (RT-qPCR) on the collected swab samples. Further, they performed whole-genome sequencing (WGS) on the samples testing positive for the SARS-CoV-2 nucleocapsid (N1) gene.
Between June 8, 2020, and November 30, 2021, they collected blood samples of pet animals from owners with SARS-CoV-2 infection two weeks to three months previously. They analyzed these samples using an enzyme-linked immunosorbent assay (ELISA) to detect immunoglobulin G (IgG) or IgM against SARS-CoV-2 spike (S) protein.
They performed the surrogate virus neutralization test (sVNT) on the first 42 serum samples and the remaining 70 samples with IgG optical density (OD) greater than 1.4. The sVNT test determines whether the interaction of the receptor-binding domain (RBD) and the angiotensin-converting enzyme 2 (ACE2) receptor is blocked.
Lastly, the researchers asked pet owners to complete an online survey for information regarding household demographics, their interaction with pets, and any new illnesses in them.
There were 283 swab samples from pet cats, dogs, and ferrets. The samples of six animals tested positive in RT-qPCR with N1 PCR cycle threshold (CT) values <35.99. WGS-sequenced samples from two RT-PCR-positive cats were assigned lineage B.1.2 and A.23.1 during phylogenetic analysis. The sequences were similar to human SARS-CoV-2 sequences from the same geographic region.
The IgG and IgM seropositivity was 25–48% at a standard deviation (SD) greater than six, above the mean cutoff for the negative control. While at greater than six SD, all IgM positive dogs were IgG positive, 25% of cats were IgG positive but IgM negative.
For dogs, the researchers observed a statistically significant correlation between seropositivity and the onset of the new respiratory infection at the time owner contracted COVID-19. However, they did not observe an association between time spent every day with the SARS-CoV-2-infected owner for both dogs and cats. Likewise, there was no effect of multiple pets or more than one confirmed COVID-19-positive case in the household.
Sleeping in the owner’s bed was a risk factor for seropositivity in cats with an odds ratio (OR) of 5.8, as indicated by a univariable risk analysis. However, it was not the case with dogs. Of the 53 samples analyzed via sVNT, 76% of samples positive on sVNT were also positive for IgG and IgM at six SD. Upon repeating risk factor analysis using the samples tested by sVNT, the authors noted that licking the hands or face of owners was associated with seropositivity for dogs, with OR=10.5.
The authors also noted a significant correlation between the ELISA OD and the neutralization of virus binding. Notably, the correlation between ELISA and sVNT results was higher for cats than dogs.
Although the study data confirmed the transmission of SARS-CoV-2 from infected humans to their pets, PCR-based detection indicated the brevity and transient nature of SARS-CoV-2 infection in pets, as observed in experiments with cats. The observed seropositivity was much higher than PCR positivity in pet animals. It is noteworthy that serologic data represent historical exposure and does not require sampling during the narrow infection window. Accordingly, a relatively high proportion of dogs and cats had antibodies to SARS-CoV-2 S protein, indicating infection or exposure. Moreover, the svNT results correlated with the ELISA results. Despite small sample sizes, risk factor analyses identified correlations linked to the duration and closeness of human-animal contact.
Cat-to-cat SARS-CoV-2 transmission has been identified. Therefore, the zoonotic risk posed by cats is probably higher, but the actual risk for a cat-to-human transmission is unknown. Nevertheless, confirmed human to dog and human to cat transmission highlight the need for further study to understand the animal and human health consequences of spillback of SARS-CoV-2 into pet animals.
- Dorothee Bienzle, Joyce Rousseau, David Marom, Jennifer MacNicol, Linda Jacobson, Stephanie Sparling, Natalie Prystajecky, Erin Fraser, and J. Scott Weese, Risk factors for SARS-CoV-2 infection and illness in cats and dogs, Emerging Infectious Diseases 2022, DOI: 10.3201/eid2806.220423, https://wwwnc.cdc.gov/eid/article/28/6/22-0423_article